1. Home
  2. DCBO vs EOLS Comparison

DCBO vs EOLS Comparison

Compare DCBO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Docebo Inc.

DCBO

Docebo Inc.

HOLD

Current Price

$19.37

Market Cap

544.8M

Sector

N/A

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$5.98

Market Cap

454.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCBO
EOLS
Founded
2016
2012
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
544.8M
454.4M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
DCBO
EOLS
Price
$19.37
$5.98
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$32.00
$15.50
AVG Volume (30 Days)
74.4K
770.3K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$12.89
$13.27
Revenue Next Year
$11.44
$17.62
P/E Ratio
$22.04
N/A
Revenue Growth
N/A
11.61
52 Week Low
$14.39
$3.86
52 Week High
$33.42
$9.58

Technical Indicators

Market Signals
Indicator
DCBO
EOLS
Relative Strength Index (RSI) 56.28 42.21
Support Level $16.37 $5.99
Resistance Level $19.66 $7.16
Average True Range (ATR) 0.84 0.35
MACD 0.08 -0.07
Stochastic Oscillator 59.94 30.73

Price Performance

Historical Comparison
DCBO
EOLS

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: